Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Tagatose is a rare monosaccharide sugar that has attracted attention for its potential metabolic benefits, including effects on triglyceride levels. Several clinical studies and reviews have explored its impact on lipid metabolism. Evidence suggests that tagatose, when used as a sweetener substitute, may help reduce postprandial triglyceride levels and overall serum triglycerides in individuals with prediabetes, type 2 diabetes, or mild hyperlipidemia. The proposed mechanisms include decreased intestinal absorption of carbohydrates, modulation of hepatic lipid synthesis, and effects on insulin sensitivity. Notable studies, such as those published in the journals Diabetes, Obesity and Metabolism (2011) and Nutrition Research (2009), have demonstrated modest reductions in triglycerides with daily tagatose supplementation compared to control sweeteners, though results are not always consistent across all populations or study designs.

While tagatose is not a traditional remedy for hypertriglyceridemia, scientific validation exists from small- to medium-sized randomized controlled trials and mechanistic studies. These findings suggest tagatose could be a beneficial adjunct for managing elevated triglycerides, primarily via dietary substitution for sucrose or fructose. However, because the body of evidence is not yet extensive and longer-term, larger studies are still needed, the overall rating for evidence strength is moderate (3/5).

More about Tagatose
More about Triglycerides (high)

Other ingredients used for Triglycerides (high)

Other health conditions supported by Tagatose

Products containing Tagatose